Tapewire

Nasdaq · USD

LNAI

Lunai Bioworks Inc.

Export transactions ↓
Tapewire entity
7981
SEC CIK
0001527728
Parsed reports
159

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 80,000 Not disclosed Strike: $2.15 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 7

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2032-10-18

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F5 · derivative.exercise_date: One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
GrantOption to Purchase Common Stock · Derivative 75,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 6

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2032-07-22

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 75,000 Not disclosed Strike: $2.38 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 5

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,000 shares

Expires 2032-07-22

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F4 · derivative.exercise_date: The option vested on January 22, 2023.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
GrantOption to Purchase Common Stock · Derivative 60,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 4

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-10-26

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 60,000 Not disclosed Strike: $8.58 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 3

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,000 shares

Expires 2031-10-26

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F3 · derivative.exercise_date: The option vested in three equal installments on October 26, 2021, October 26, 2022 and October 26, 2023.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
GrantOption to Purchase Common Stock · Derivative 60,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 2

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2029-06-06

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 60,000 Not disclosed Strike: $6.15 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 1

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,000 shares

Expires 2029-06-06

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F1 · derivative.exercise_date: The option vested in three equal installments on January 7, 2019, January 7, 2020 and January 7, 2021.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to Purchase Common Stock · Derivative 350,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 12

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2032-08-25

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F4 · derivative.exercise_date: One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 350,000 Not disclosed Strike: $2.54 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 11

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 350,000 shares

Expires 2032-08-25

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F4 · derivative.exercise_date: One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to Purchase Common Stock · Derivative 2,000,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 10

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 2,000,000 shares

Expires 2031-07-19

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F3 · derivative.exercise_date: The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 2,000,000 Not disclosed Strike: $4.57 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 9

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000,000 shares

Expires 2031-07-19

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F3 · derivative.exercise_date: The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to Purchase Common Stock · Derivative 450,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 8

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2031-06-11

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 450,000 Not disclosed Strike: $8.00 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 7

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 450,000 shares

Expires 2031-06-11

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to Purchase Common Stock · Derivative 300,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 6

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2028-11-21

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 300,000 Not disclosed Strike: $6.50 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 5

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 300,000 shares

Expires 2028-11-21

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to Purchase Common Stock · Derivative 5,226 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 4

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,226

Underlying: Common Stock · 5,226 shares

Expires 2028-09-19

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 5,226 Not disclosed Strike: $5.74 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 3

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,226 shares

Expires 2028-09-19

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to Purchase Common Stock · Derivative 7,563 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 2

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,563

Underlying: Common Stock · 7,563 shares

Expires 2028-02-28

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:06 UTC
Dybul MarkDirector · Chief Executive Officer
Disposition to issuerOption to Purchase Common Stock · Derivative 7,563 Not disclosed Strike: $5.95 Not disclosed
Disclosure

SEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 1

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,563 shares

Expires 2028-02-28

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F1 · derivative.exercise_date: The option vested in three equal installments on February 28, 2019, February 28, 2020 and February 28, 2021.

Read SEC document
February 13, 2024 Filed Feb 20, 2024 21:20 UTC ConversionSeries A Convertible Preferred Stock · Derivative 343,619 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-24-015328 · ownership.xml · derivative · entry 4

Abildgaard Ole · CIK 0001994976 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 3,436,190 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Preferred Stock is convertible into common stock on a 1-for-10 basis.

F4 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date.

F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer.

Read SEC document
February 13, 2024 Filed Feb 20, 2024 21:20 UTC ConversionCommon Stock 3,436,190 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 1

Abildgaard Ole · CIK 0001994976 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,898,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of common stock on a 1-for-10 basis pursuant to their terms upon the closing of the issuer's acquisition of GEDi Cube Int. Ltd. pursuant to that certain Stock Purchase Agreement, dated September 28, 2023, by and among the issuer, GEDi Cube Intl Ltd., the other sellers party thereto, and Yalla Yalla Ltd., in its capacity as the representative of the sellers.

F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer.

Read SEC document
December 27, 2023 Filed Feb 2, 2024 17:14 UTC GrantOption to purchase shares of common stock · Derivative 23,810 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001731122-24-000185 · ownership.xml · derivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,810

Underlying: Common stock · 23,810 shares

Expires 2033-12-27

Read SEC document
December 27, 2023 Filed Feb 28, 2024 20:20 UTC GrantOption to purchase shares of common stock · Derivative 23,810 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001731122-24-000322 · ownership.xml · derivative · entry 1

Brosgart Carol L · CIK 0001614724 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,810

Underlying: Common stock · 23,810 shares

Expires 2033-12-27

Read SEC document
October 23, 2023 Filed Nov 14, 2023 09:56 UTC
Miller AvramDirector
GrantOption to purchase shares of common stock · Derivative 27,147 $0.00 Strike: $2.76 $0.00
Disclosure

SEC source: 0001731122-23-002098 · ownership.xml · derivative · entry 2

Miller Avram · CIK 0002000641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,147

Underlying: Common stock · 27,147 shares

Expires 2033-10-11

Read SEC document
October 23, 2023 Filed Nov 14, 2023 09:56 UTC
Miller AvramDirector
GrantCommon Stock 1,000,000 $0.00 $0.00
Disclosure

SEC source: 0001731122-23-002098 · ownership.xml · nonDerivative · entry 1

Miller Avram · CIK 0002000641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

F1 · date: On October 11, 2023, the Reporting Person entered into an Advisory Agreement, pursuant to which the Issuer agreed to issue Mr. Miller 1,000,000 shares of restricted stock, 166,667 of which will vest in 2024, 444,444 will vest in 2025, and 388,889 will vest in 2026, subject to Mr. Miller's continued service through each applicable vesting date.

Read SEC document
October 09, 2023 Filed Oct 19, 2023 17:09 UTC GrantOption to purchase shares of common stock · Derivative 17,242 $0.00 Strike: $4.35 $0.00
Disclosure

SEC source: 0001731122-23-001919 · ownership.xml · derivative · entry 1

Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,242

Underlying: Common stock · 17,242 shares

Expires 2033-10-09

Read SEC document
October 04, 2023 Filed Oct 25, 2023 14:56 UTC
Boeren LeniDirector
GrantOption to purchase shares of common stock · Derivative 16,129 $0.00 Strike: $4.65 $0.00
Disclosure

SEC source: 0001731122-23-001947 · ownership.xml · derivative · entry 1

Boeren Leni · CIK 0001998190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,129

Underlying: Common stock · 16,129 shares

Expires 2033-10-04

Read SEC document
October 04, 2023 Filed Oct 27, 2023 10:53 UTC GrantOption to purchase shares of common stock · Derivative 16,129 $0.00 Strike: $4.65 $0.00
Disclosure

SEC source: 0001731122-23-001972 · ownership.xml · derivative · entry 1

Hendriks Ruud · CIK 0001996999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,129

Underlying: Common stock · 16,129 shares

Expires 2033-10-04

Read SEC document
October 03, 2023 Filed Feb 20, 2024 21:20 UTC GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 2

Abildgaard Ole · CIK 0001994976 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,398,482

F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer.

Read SEC document
August 22, 2023 Filed Feb 20, 2024 21:20 UTC GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 3

Abildgaard Ole · CIK 0001994976 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,898,482

F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer.

Read SEC document
August 01, 2023 Filed Sep 12, 2023 10:08 UTC
Sindlev ReneDirector · 10% owner
GrantWarrant (Right to Buy) · Derivative 350,630 $0.00 Strike: $0.65 $0.00
Disclosure

SEC source: 0001731122-23-001669 · ownership.xml · derivative · entry 2

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 350,630

Underlying: Common Stock · 350,630 shares

Expires 2028-08-01

F3 · price: Granted to the Reporting Person as warrant coverage in connection with the Preferred Stock reported above.

Read SEC document
August 01, 2023 Filed Sep 12, 2023 10:08 UTC
Sindlev ReneDirector · 10% owner
GrantSeries A Convertible Preferred Stock · Derivative 70,126 $7.13 Strike: $0.00 $499,998.38
Disclosure

SEC source: 0001731122-23-001669 · ownership.xml · derivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 70,126

Underlying: Common Stock · 701,260 shares

Expires not disclosed

F1 · derivative.exercise_price: The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis

F2 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date.

Read SEC document
July 30, 2023 Filed Aug 1, 2023 23:47 UTC
Sindlev ReneDirector · 10% owner
GrantOption to purchase shares of Common Stock · Derivative 131,579 $0.00 Strike: $0.57 $0.00
Disclosure

SEC source: 0001731122-23-001334 · ownership.xml · derivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,579

Underlying: Common Stock · 131,579 shares

Expires 2033-07-30

Read SEC document
June 26, 2023 Filed Jun 28, 2023 00:29 UTC
Sindlev ReneDirector · 10% owner
GrantWarrant (Right to Buy) · Derivative 943,397 $0.00 Strike: $0.53 $0.00
Disclosure

SEC source: 0001731122-23-001221 · ownership.xml · derivative · entry 2

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 943,397

Underlying: Common Stock · 943,397 shares

Expires 2028-06-26

F1 · price: Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I.

Read SEC document
June 26, 2023 Filed Jun 28, 2023 00:29 UTC
Sindlev ReneDirector · 10% owner
GrantCommon Stock 1,886,794 $0.53 $1,000,000.82
Disclosure

SEC source: 0001731122-23-001221 · ownership.xml · nonDerivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 12,432,338

Read SEC document
May 26, 2023 Filed Jun 15, 2023 01:26 UTC GrantOption to Purchase Common Stock · Derivative 79,787 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001731122-23-001136 · ownership.xml · derivative · entry 1

McNicol Jayne · CIK 0001866827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,787

Underlying: Common Stock · 79,787 shares

Expires 2033-05-26

Read SEC document
March 17, 2023 Filed Mar 22, 2023 01:39 UTC
Sindlev ReneDirector · 10% owner
GrantWarrant (Right to Buy) · Derivative 438,597 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001731122-23-000444 · ownership.xml · derivative · entry 2

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 438,597

Underlying: Common Stock · 438,597 shares

Expires 2028-03-17

F1 · price: Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I.

Read SEC document
March 17, 2023 Filed Mar 22, 2023 01:39 UTC
Sindlev ReneDirector · 10% owner
GrantCommon Stock 877,193 $1.14 $1,000,000.02
Disclosure

SEC source: 0001731122-23-000444 · ownership.xml · nonDerivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 10,545,544

Read SEC document
March 06, 2023 Filed Apr 4, 2023 20:07 UTC GrantOption to Purchase Common Stock · Derivative 64,655 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001731122-23-000571 · ownership.xml · derivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,655

Underlying: Common Stock · 64,655 shares

Expires 2033-03-06

Read SEC document
December 27, 2022 Filed Jan 5, 2023 21:47 UTC GrantOption to purchase shares of common stock · Derivative 57,252 $0.00 Strike: $1.31 $0.00
Disclosure

SEC source: 0001731122-23-000019 · ownership.xml · derivative · entry 1

Brosgart Carol L · CIK 0001614724 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,252

Underlying: Common stock · 57,252 shares

Expires 2032-12-27

Read SEC document
December 27, 2022 Filed Jan 5, 2023 21:48 UTC GrantOption to purchase shares of common stock · Derivative 57,252 $0.00 Strike: $1.31 $0.00
Disclosure

SEC source: 0001731122-23-000021 · ownership.xml · derivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,252

Underlying: Common stock · 57,252 shares

Expires 2032-12-27

Read SEC document
October 18, 2022 Filed Oct 27, 2022 20:54 UTC
Binette FrancoisExecutive VP for R&D
GrantOption to purchase shares of common stock · Derivative 40,000 $0.00 Strike: $2.15 $0.00
Disclosure

SEC source: 0001731122-22-001812 · ownership.xml · derivative · entry 1

Binette Francois · CIK 0001940686 · Executive VP for R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common stock · 40,000 shares

Expires 2032-10-18

F1 · derivative.exercise_date: This option vests ratably over three years commencing on October 18, 2023.

Read SEC document
October 18, 2022 Filed Oct 27, 2022 20:51 UTC
Puche LuisaChief Financial Officer
GrantOption to purchase shares of common stock · Derivative 80,000 $0.00 Strike: $2.15 $0.00
Disclosure

SEC source: 0001731122-22-001810 · ownership.xml · derivative · entry 1

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2032-10-18

F1 · derivative.exercise_date: This option vests ratably over three years commencing on October 18, 2023.

Read SEC document
October 13, 2022 Filed Feb 6, 2023 19:31 UTC OtherCommon Stock 1,216,467 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-23-001677 · marketforms-58231.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,313,499

F1 · kind: Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement.

F1 · price: Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
October 13, 2022 Filed Feb 7, 2023 00:24 UTC OtherCommon Stock 1,216,467 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-23-001671 · marketforms-58228.xml · nonDerivative · entry 8

Weird Science LLC · CIK 0001955760 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,313,499

F2 · kind: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.

F2 · price: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.

Read SEC document
October 09, 2022 Filed Oct 26, 2022 20:19 UTC GrantOption to purchase shares of common stock · Derivative 45,455 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001731122-22-001803 · ownership.xml · derivative · entry 1

Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,455

Underlying: Common stock · 45.455 shares

Expires 2032-10-09

Read SEC document
August 25, 2022 Filed Sep 15, 2022 16:36 UTC
Dybul MarkDirector · Chief Executive Officer
GrantOption to purchase shares of common stock · Derivative 350,000 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001731122-22-001581 · ownership.xml · derivative · entry 1

Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common stock · 350,000 shares

Expires 2032-08-25

F1 · derivative.exercise_date: The options vest ratably on August 25, 2023, August 25, 2024 and August 25, 2025.

Read SEC document
July 30, 2022 Filed Oct 25, 2022 20:21 UTC
Sindlev ReneDirector · 10% owner
GrantOption to Purchase Shares of Common Stock · Derivative 32,609 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001731122-22-001787 · ownership.xml · derivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,609

Underlying: Common Stock · 32,609 shares

Expires 2032-07-30

Read SEC document
July 20, 2022 Filed Jul 26, 2022 23:02 UTC
Puche LuisaChief Financial Officer
GrantOption to purchase shares of common stock · Derivative 75,000 $0.00 Strike: $2.38 $0.00
Disclosure

SEC source: 0001731122-22-001245 · ownership.xml · derivative · entry 1

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common stock · 75,000 shares

Expires 2032-07-20

F1 · shares: The option was issued in connection with the Company's employee retention plan.

Read SEC document
June 08, 2022 Filed Jul 18, 2022 10:02 UTC
Sindlev ReneDirector · 10% owner
OtherCommon Stock 128,493 Not disclosed Not disclosed
Disclosure

SEC source: 0001731122-22-001223 · ownership.xml · nonDerivative · entry 2

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By RS Group ApS

Disclosed balance after: 0

F2 · kind: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.

F2 · price: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.